IUPAC Traditional

2-chloro-1-{4-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]piperazin-1-yl}ethan-1-one

Compound number MolPort-002-468-882
Molecular weight 310.78
InChI key PTZPMYNSAPNERP-UHFFFAOYSA-N
Molecular formula C15H19ClN2O3
DMSO Solubility Unknown
SMILES ClCC(=O)N1CCN(Cc2ccc3OCCOc3c2)CC1
Best offer
$383.00
Including direct shipping

Pack size:
1 g
Shipping to:
United States
Lead time:
26 business days
Adjust Requirements

BLD Pharmatech (made-to-order)

Direct S&H to USA
90.00 USD
Catalog
Building blocks
Ships out
26 business days
Purity
98%
Last updated
today
In warehouse
Unverified

Supplier Catalogue Data

Pack size
Ships out
Price
Quantity
1 g
March 8, 2023
293.00 USD
Simpler, smarter compound sourcing with Molport
  • Extensive vetted supplier network
  • Smart standardised systems and intelligent fulfilment
  • Experienced support and expert lab services
We supply companies including
Fraunhofer logo Domainex logo Reverie labs logo
Search and order chemical compounds instantly
View search options
Access and search our databases offline
Access databases

More Information

Compound identifiers

Compound number
MolPort-002-468-882
CAS number
853574-38-6

Names, Synonyms and 3rd Party Identifiers

Name
1-(chloroacetyl)-4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)piperazine
2-chloro-1-[4-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)piperazin-1-yl]ethan-1-one
MFCD06655713

InChI

InChI
1/C15H19ClN2O3/c16-10-15(19)18-5-3-17(4-6-18)11-12-1-2-13-14(9-12)21-8-7-20-13/h1-2,9H,3-8,10-11H2
InChI key
PTZPMYNSAPNERP-UHFFFAOYSA-N

Formula

Molecular formula
C15H19ClN2O3
Molecular weight
310.78

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback